US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist
  • 2.900
  • +0.030+1.04%
Trading Jul 22 09:36 ET
174.23MMarket Cap-2761P/E (TTM)

About Acumen Pharmaceuticals Company

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.

Company Profile

SymbolABOS
Company NameAcumen Pharmaceuticals
Listing DateJul 1, 2021
Issue Price16.00
Founded1996
CEOMr. Daniel O'Connell
MarketNASDAQ
Employees52
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address427 Park Street
CityCharlottesville
ProvinceVirginia
CountryUnited States of America
Zip Code22902
Phone1-434-297-1000
Websitehttp://www.acumenpharm.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel O'Connell
  • Director and Chief Executive Officer
  • 3.93M
  • William Matthew Zuga
  • Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
  • 1.61M
  • Russell Barton, M.S.
  • Chief Operating Officer
  • --
  • Derek M. Meisner
  • Chief Legal Officer
  • 1.48M
  • Dr. Jim Doherty, PhD
  • President and Chief Development Officer
  • --
  • James J. Doherty
  • President and Chief Development Officer
  • --
  • Dr. Eric Siemers, M.D.
  • Chief Medical Officer
  • --
  • Sean Stalfort
  • Chairman of the Board
  • 173.52K
  • Dr. Nathan B. Fountain, M.D.
  • Independent Director
  • 135.02K
  • Dr. Laura Stoppel, PhD
  • Independent Director
  • 147.52K
  • Dr. Jeffrey L. Ives, PhD
  • Independent Director
  • 141.02K
  • Dr. Derrell D. Porter, M.D.
  • Independent Director
  • 339.81K
  • Dr. Kimberlee Cobleigh Drapkin, PhD
  • Independent Director
  • 152.27K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg